HIV #vaccine scientific progress and challenges by IAVI
Hansi Dean, Director New Alliances at International AIDS Vaccine Initiative (IAVI) delivered a presentation on HIV vaccine scientific progress and challenges at the World Vaccine Congress Lyon 2011
Key topics raised on her presentation included:
- The HIV prevention landscape
- Broadly neutralizing human monoclonal antibodies
- IAVI-corporate partnerships in HIV vaccine design
Watch the video now or download the pdf presentation here
Enjoy the presentation!
The 2012 World Vaccine Congress Lyon is taking place on 16th – 18th October and it is the best place to meet over 400 senior vaccine professionals to forge new partnerships and discover new commercial opportunities. Visit the website www.terrapinn.com/2012/world-vaccine-congress-lyon
at 2:12 am
A recent discovery by AIDS researchers suggests that the potential immune antibody also known V1/V2 region is likely to be protective. This has led to further studies using similar regimen. The trials involve more than 600 volunteers and is aimed at evaluating immunity boosting strategies for noninfected participants.